Experts in Residence
The “Experts in Residence” scheme is managed by the Translational Research Office, the Business Partnerships Office and Oxford University Innovation. It aims to give Oxford's research community access to world-leading expertise and advice across multiple industry sectors. Scientists can arrange meetings with our experts to discuss their ideas and projects with no strings attached. We expect that this advice and support will help scientists develop the translational strategy for their projects/technologies.
Our Experts
Book a meeting with one of our Experts in Residence
Product Design in Biomedical Engineering
Patrick Hall, Managing Director, Designing Science Ltd
Kerry Briggs, Head of Medical, Kinneir Dufort
James Holmes, Head of Electronics, Kinneir Dufort
Rouzet Agaiby, Associate Director, eg technology
Imaging technologies
Dr Jan Wolber, Product Leader - Digital, GE Healthcare Pharmaceutical Diagnostics
Drug Discovery and development
Dr Rachel Grimley, Senior Vice President, Drug discovery, Cancer Research UK
Professor Simon Hollingsworth, VP, Global Medicine Leader, AstraZeneca
Dr Rachel Hemsley, Global Head of Business Development, Xenogesis
Dr Colin T Dourish, Director and Co-Owner of P1vital and P1vital Products
Dr Anthony Brown, VP Business Development & Scientific Liaison, Carrick Therapeutics
Dr Holger Hess-Stumpp, Former Director, Strategic Alliance Manager Oncology, Bayer,
Professor David Reynolds, CEO of LoQus 23 and AstronauTx
Dr Tom Oakley, VP EU Regulatory Affairs, Propharma Group
Digital Health
Dr Steve Gardner, Co-founder and CEO, PrecisionLife
Dr Veronique Bouchet, Chief Medical Officer, PrecisionLife;
Paul O'Donohoe, Scientific Lead, eCOA and Mobile Health, Medidata Solutions;
Bobby Kaura, Seed Investment, EMEA Outreach & International Development, Illumina Accelerator
Medical Technologies - Regulatory and Market Access
Dr Toni Day, Director of Quality and Regulatory Affairs at OrganOx
Richard Hall, QMS Consultancy
Ben Wensley-Stock, Managing Director MPS-UK and Wensley Stock Ltd
Dr Steven Haken, Director at Odelle Technology
Diagnostics
Dr Adam Hill, Ceo of Oncimmune
Clinical Research
Dr Steve McConchie, CEO of Aptus
Matthew Reaney, Head of Patient Centered Endpoints, Science & Analytical Teams, IQVIA
Professor Jeremy Kirk, R&D Director Birmingham Women and Children’s Hospital and former CD NIHR Clinical Research Network for West Midlands
Innovation and commercial opportunities
Paul Cox, General Manager, Apellis Pharmaceuticals
Nicholas Duggan, Partner at Viadynamics
Dr Joanne Hackett, IZY Capital
Dr Laura Ferguson, AstraZeneca
Dr Karen Wai, KW Health Advisory